Diabetes
Livin' on the MDedge
A purple warrior rises in the battle against diabetes
Plus: Rare honey builds strong but bacteria-prone bone implants, and mycoprotein builds strong gut microbiomes.
Conference Coverage
Metformin linked to reductions in COVID-19 viral load
Key questions the findings raise include whether the results correlate with clinical outcomes or transmission, and whether the findings are...
Feature
How to get started with prescribing and advising on CGM
Continuous glucose monitoring is gaining ground with both patients and providers because of an array of driving forces.
From the Journals
Diabetes drug tied to lower dementia risk
Risk for dementia is doubled in adults with T2DM, say the authors of a new paper.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
From the Journals
Type 1 diabetes no longer a disease of the thin: Lifestyle advice needed
The prevalence of overweight/obesity was similar for people with type 1 diabetes and those without diabetes in a nationwide survey.
Commentary
The 5-year survival rate for pancreatic cancer is increasing
‘Research is making a difference. And we’re making progress against cancer in general,’ says expert.
Latest News
‘Forever chemicals’ up type 2 diabetes risk in midlife White women
“A new finding is that we observed some phthalates are associated with a higher risk of diabetes development, especially in White women [that]...
From the Journals
Longer life after bariatric surgery, but suicide risk in young
Death from diabetes was 72% lower in the bariatric surgery patients versus nonsurgery peers.
Commentary
Keto for life? Reasons to think twice
Is the Keto diet best for weight loss? Maybe in the short term, but it’s more complicated than that. Dr. Caroline Apovian explains why.
From the Journals
Persistent gaps in drug use by patients with type 2 diabetes
Continuous use of glucose-, BP-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may...